Oct 18 (Reuters) - Abbvie Inc
* Abbvie and Harpoon Therapeutics announce immuno-oncology research collaboration
* Abbvie Inc - financial terms were not disclosed.
* Abbvie Inc - under terms of agreement, Harpoon will engineer tritac molecules directed against selected cancer targets using its proprietary platform
* Abbvie Inc says Harpoon will provide Abbvie right to pursue further development and commercialization of the tritac molecules
* Abbvie - collaboration to incorporate Harpoon’s tritac platform with co’s research-stage immuno-oncology targets to develop novel cancer therapeutics Source text for Eikon: Further company coverage: (Bangalore.firstname.lastname@example.org)